Anesth Analg 2004;98:336-342
© 2004 International Anesthesia Research Society
doi: 10.1213/01.ANE.0000093390.94921.4A
AMBULATORY ANESTHESIA
Effective Treatment of Laparoscopic Cholecystectomy Pain with Intravenous Followed by Oral COX-2 Specific Inhibitor
Girish P. Joshi, MBBS MD,
Eugene R. Viscusi, MD,
Tong J. Gan, MD,
Harold Minkowitz, MD,
Mark Cippolle, MD PhD,
Rienhard Schuller, MSc,
Raymond Y. Cheung, BPharm PhD, and
John G. Fort, MD
From the Department of Anesthesiology and Pain Management, University of Texas Southwestern Medical Center, Dallas, Texas
Address correspondence to Girish P. Joshi, MBBS, MD, FFARCSI, Professor of Anesthesiology and Pain Management, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390-9068. Address email to girish.joshi{at}utsouthwestern.edu
In this multicenter, double-blinded, randomized, placebo-controlled study we evaluated the analgesic and opioid-sparing efficacy of a preoperative dose of IV parecoxib followed by oral valdecoxib in treating pain associated with elective laparoscopic cholecystectomy. Patients were randomized to receive a single IV dose of parecoxib 40 mg (n = 134) or placebo (n = 129) 3045 min before induction of anesthesia. Six to 12 h after the IV dose, the parecoxib group received a single oral dose of valdecoxib 40 mg, followed by valdecoxib 40 mg qd on postoperative days 14, then 40 mg qd prn days 57. The placebo IV group received oral placebo on an identical schedule. All patients were allowed supplemental IV fentanyl as needed during the first 4 h postoperatively (T0240 min) followed by hydrocodone 5 mg/acetaminophen 500 mg (Vicodin®; 12 tablets orally every 46 h as needed). Patients taking parecoxib used 21% less fentanyl than those receiving placebo (P = 0.011). The mean area under the curve of pain intensity (PI) scores over time from T0240 min was 55.2 for parecoxib and 61.2 for placebo (P = 0.083). At T180 and T240 min, mean PI score was 7.0 and 7.6 points lower in the parecoxib group, respectively (P < 0.02). Fewer patients on valdecoxib required supplemental analgesics (P < 0.05) after discharge. At T240 min and at day 7, Patients and Physicians/Nurses Global Evaluations were significantly better in the parecoxib/valdecoxib group (P < 0.05). Incidences of adverse events, adverse events causing withdrawal, and serious adverse events were less for parecoxib/valdecoxib than for placebo. The authors conclude that preoperative parecoxib is a valuable opioid-sparing adjunct to the standard of care for treating pain after laparoscopic cholecystectomy, and subsequent treatment with oral valdecoxib extends this clinical benefit.
IMPLICATIONS: Parecoxib 40 mg IV, 3045 min preoperatively followed by oral valdecoxib 40 mg qd reduced opioid requirements and provided superior pain relief as well as improved patient global evaluation after laparoscopic cholecystectomy.
This article has been cited by other articles:

|
 |

|
 |
 
S. A. Schug, G. P. Joshi, F. Camu, S. Pan, and R. Cheung
Cardiovascular Safety of the Cyclooxygenase-2 Selective Inhibitors Parecoxib and Valdecoxib in the Postoperative Setting: An Analysis of Integrated Data
Anesth. Analg.,
January 1, 2009;
108(1):
299 - 307.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Riest, J. Peters, M. Weiss, S. Dreyer, P. D. Klassen, B. Stegen, A. Bello, and M. Eikermann
Preventive effects of perioperative parecoxib on post-discectomy pain
Br. J. Anaesth.,
February 1, 2008;
100(2):
256 - 262.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Martinez, A. Belbachir, A. Jaber, K. Cherif, A. Jamal, Y. Ozier, D. I. Sessler, M. Chauvin, and D. Fletcher
The Influence of Timing of Administration on the Analgesic Efficacy of Parecoxib in Orthopedic Surgery
Anesth. Analg.,
June 1, 2007;
104(6):
1521 - 1527.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Pollak, G. A. Raymond, R. M. Jay, H. J. Hillstrom, K. T. Mahan, D. Riff, E. L. Jacobs, M. T. Brown, and K. M. Verburg
Analgesic efficacy of valdecoxib for acute postoperative pain after bunionectomy.
J Am Podiatr Med Assoc,
September 1, 2006;
96(5):
393 - 407.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. F. White
Safety of Cox-2 Selective Nonsteroidal Antiinflammatory Drugs for Postsurgical Pain
Anesth. Analg.,
February 1, 2006;
102(2):
646 - 646.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. F. White
The Changing Role of Non-Opioid Analgesic Techniques in the Management of Postoperative Pain
Anesth. Analg.,
November 1, 2005;
101(5S_Suppl):
S5 - 22.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Opstelten, G. A van Essen, K. G. Moons, A. J. van Wijck, F. G Schellevis, C. J Kalkman, and T. J. Verheij
Do herpes zoster patients receive antivirals? A Dutch national survey in general practice
Fam. Pract.,
October 1, 2005;
22(5):
523 - 528.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Bonnet and E. Marret
Influence of anaesthetic and analgesic techniques on outcome after surgery
Br. J. Anaesth.,
July 1, 2005;
95(1):
52 - 58.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. F. White
Changing Role of COX-2 Inhibitors in the Perioperative Period: Is Parecoxib Really the Answer?
Anesth. Analg.,
May 1, 2005;
100(5):
1306 - 1308.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. A. Nussmeier, A. A. Whelton, M. T. Brown, R. M. Langford, A. Hoeft, J. L. Parlow, S. W. Boyce, and K. M. Verburg
Complications of the COX-2 Inhibitors Parecoxib and Valdecoxib after Cardiac Surgery
N. Engl. J. Med.,
March 17, 2005;
352(11):
1081 - 1091.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-T. Wu, C. O Borel, M.-S. Lee, J.-C. Yu, H.-S. Liou, H.-D. Yi, and C.-P. Yang
The Interaction Effect of Perioperative Cotreatment with Dextromethorphan and Intravenous Lidocaine on Pain Relief and Recovery of Bowel Function After Laparoscopic Cholecystectomy
Anesth. Analg.,
February 1, 2005;
100(2):
448 - 453.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Apfelbaum, T. J. Gan, S. Zhao, D. B. Hanna, and C. Chen
Reliability and Validity of the Perioperative Opioid-Related Symptom Distress Scale
Anesth. Analg.,
September 1, 2004;
99(3):
699 - 709.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. F. Ekman and L. A. Koman
Acute Pain Following Musculoskeletal Injuries and Orthopaedic Surgery. Mechanisms and Management
J. Bone Joint Surg. Am.,
June 1, 2004;
86(6):
1316 - 1327.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Gan, G. P. Joshi, E. Viscusi, R. Y. Cheung, W. Dodge, J. G. Fort, and C. Chen
Preoperative Parenteral Parecoxib and Follow-Up Oral Valdecoxib Reduce Length of Stay and Improve Quality of Patient Recovery After Laparoscopic Cholecystectomy Surgery
Anesth. Analg.,
June 1, 2004;
98(6):
1665 - 1673.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|